Funding

California-Based Bioness Medical Receives $15M Credit Facility

Sep 5, 2026 | By Devin Jacobs

SUMMARY

Bioness Medical received a $15M credit facility.
The funding will support growth and product expansion.
Bioness develops neurorehabilitation technologies.

Bioness Medical, a Valencia, CA-based provider of FDA-approved neurorehabilitation technologies designed to improve mobility, has received a $15M credit facility led by Horizon Technology Finance Corporation.

The company will use the financing to invest in innovation, expand its product portfolio, and support continued growth in the neurorehabilitation market.

Funding Snapshot

Metric	Details
Fundraise Amount	$15 Million Credit Facility
Valuation	Not disclosed
Company	Bioness Medical
Sector	Healthcare / Neurorehabilitation
Headquarters	Valencia, California, USA

RECOMMENDED FOR YOU

Startup News

Feature.fm and SonoSuite Partner to Bring Marketing Automation

Devin Jacobs

Jun 8, 2026

Funding

Tycho AI Raises $10M in Series A Funding

Startuprise

Oct 8, 2025

Funding

[Funding news] NYC-based Vensica Medical Secures $11Million in Funding

Team SR

Oct 29, 2024

About Bioness Medical

Founded in 2004, Bioness Medical develops and commercializes FDA-approved technologies designed to improve mobility, function, and independence for people recovering from stroke, spinal cord injury, and other neurological conditions.

Its clinically validated products are used across hospitals, outpatient facilities and home based care settings. The company is backed by Accelmed Partners and serves clinicians and healthcare systems with evidence-based rehabilitation solutions.

Core offerings include:

Functional electrical stimulation
Robotic gait training
Neuromodulation technologies
Mobility and rehabilitation solutions

Core Technologies / Products / Services

Capability/Product	Application/Use Case
Functional Electrical Stimulation	Supports mobility and muscle function
Robotic Gait Training	Helps patients improve walking and movement
Neuromodulation	Supports rehabilitation and neurological recovery
Neurorehabilitation Technologies	Helps improve mobility, function, and independence

Leadership Comments

“Providing flexible growth capital to innovative companies with proven business models, and strong market positions is a core focus of Horizon’s venture lending platform,” said Paul Seitz, Chief Investment Officer of Horizon.

“Horizon’s deep understanding of the life sciences sector and ability to structure a financing solution tailored to our needs made them an attractive partner,” said Todd Cushman, Co-Founder, and Chief Executive Officer of Bioness.